China is moving fast to dominate biotechnology, and the U.S. risks falling behind permanently unless it takes action over the next three years, a congressional commission said. Congress should ...

Vir Biotechnology, Inc. (NASDAQ:VIR) today announced it will present new data from the Phase 2 SOLSTICE clinical trial evaluating the efficacy and saf ...

Market to grow from USD 2.58 Billion in 2024 to USD 6.38 Billion by 2032, at a CAGR of 12.02%.Austin, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Human Growth Hormone Market Size & Growth Analysis According to ...

This reflects a compound annual growth rate (CAGR) of 7.2%, fueled by the rising demand for eco-friendly solutions, ...

24/7 Market News Issues Corrected Information on Previously issued Press Release with same title ...

Plant biotechnology is undergoing a transformative era, driven by rapid advancements in molecular biology, genetic engineering, molecular breeding, Biopharmaceutical and synthetic biology.

Plant biotechnology is undergoing a transformative era, driven by rapid advancements in molecular biology, genetic engineering, molecular breeding, Biopharmaceutical and synthetic biology.

Vir Biotechnology, Inc. today announced it will present new data from the Phase 2 SOLSTICE clinical trial evaluating the efficacy and safety profile of tobevibart, an investigational monoclonal ...